Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
D-amino acid transaminase (DAAT) is an enzyme that catalyzes the reversible transfer of amino groups from D-amino acids to 2-oxoglutarate. It is a pyridoxal phosphate (PLP)-dependent enzyme and plays a crucial role in bacterial metabolism, particularly in the synthesis of cell wall components such as D-alanine and D-glutamate. DAATs are potential targets for novel antibacterial agents due to their essential role in bacterial cell wall synthesis and absence in higher eukaryotes.
Suicide inhibition of bacterial cell wall synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-amino acid transaminase (DAAT).